PATENT CLAIM ANALYSIS

Application Number: 16250529
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-10
Patent Classification: ["536", "017400"]

Abstract:
Described herein are conjugated modified oligonucleotides that are complementary to a target RNA. The conjugate facilitates cellular uptake of the modified oligonucleotide, resulting improved potency.

Claim (Index 108):
The compound of  claim 92 , wherein at least one linkage of the modified oligonucleotide is a modified internucleoside linkage.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 99.0
- Lexical Diversity: 1.12
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15295646', '14266127', '15056534', '14577481', '14266136']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7391824213494596
- 35 USC 102 Novelty (BERT): 0.6498129381379449
- Combined Prediction Score: 0.7302454730283081
- Mean Citation Score: 624.690016
- Max Citation Score: 694.1071
- Similarity Product: 579.2965531933188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test